Search Results - "ZECHNER, S"

  • Showing 1 - 12 results of 12
Refine Results
  1. 1

    IDEAL: a 6-month, double-blind, placebo-controlled study of the first skin patch for Alzheimer disease by Winblad, B, Grossberg, G, Frölich, L, Farlow, M, Zechner, S, Nagel, J, Lane, R

    Published in Neurology (24-07-2007)
    “…The rivastigmine patch is the first transdermal treatment for Alzheimer disease (AD). By providing continuous delivery of drug into the bloodstream over 24…”
    Get full text
    Journal Article
  2. 2

    A 6-month, double-blind, placebo-controlled study of the first skin patch for Alzheimer disease by WINBLAD, B, GROSSBERG, G, FRÖLICH, L, FARLOW, M, ZECHNER, S, NAGEL, J, LANE, R

    Published in Neurology (01-07-2007)
    “…The rivastigmine patch is the first transdermal treatment for Alzheimer disease (AD). By providing continuous delivery of drug into the bloodstream over 24…”
    Get full text
    Conference Proceeding Journal Article
  3. 3

    A six-month double-blind, randomized, placebo-controlled study of a transdermal patch in Alzheimer's disease-- rivastigmine patch versus capsule by Winblad, Bengt, Cummings, Jeffrey, Andreasen, Niels, Grossberg, George, Onofrj, Marco, Sadowsky, Carl, Zechner, Stefanie, Nagel, Jennifer, Lane, Roger

    “…Objectives To compare the efficacy, safety and tolerability of a novel rivastigmine transdermal patch with conventional rivastigmine capsules and placebo in…”
    Get full text
    Journal Article
  4. 4

    A quantitative flood risk analysis methodology for urban areas with integration of social research data by Escuder-Bueno, I, Castillo-Rodríguez, J. T, Zechner, S, Jöbstl, C, Perales-Momparler, S, Petaccia, G

    Published in Natural hazards and earth system sciences (12-09-2012)
    “…Risk analysis has become a top priority for authorities and stakeholders in many European countries, with the aim of reducing flooding risk, considering the…”
    Get full text
    Journal Article
  5. 5
  6. 6

    Contingent negative variation and attention in schizophrenic and depressed patients by Heimberg, D R, Naber, G, Hemmeter, U, Zechner, S, Witzke, W, Gerhard, U, Dittmann, V, Holsboer-Trachsler, E, Hobi, V

    Published in Neuropsychobiology (01-01-1999)
    “…Contingent negative variation (CNV) is supposed to be a psychophysiological indicator of attention and arousal. Both have been reported to be deteriorated in…”
    Get more information
    Journal Article
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12